Back to search

Peptide record

TPDB92272

Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity Tumor-homing Peptides standard
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92272
Antibacterial Anticancer Blood-Brain Barrier Cell-penetrating Peptides Toxicity Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides Delivery and barrier-penetrating peptides
Peptipedia BBPpredict CPPsite3.0 StackTHP StackTHPred TumorHoPe2.0
standard
No
A 5-aa standard natural multi-activity (Antibacterial, Anticancer, Blood-Brain Barrier, and other sources) peptide sequence curated from Peptipedia, BBPpredict, CPPsite3.0, and other sources, with an available 3D structural model.
N-terminal: N-methyl-Glu
Sequence
CREKA
Physicochemical Analysis
C23H43N9O8S1
NDQGHILMFPSTWYV
ARCEK
605.71
8.97
2
1
1
+1
3.41
-1.520
20.00
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
1
A
1
R
0
N
0
D
1
C
1
E
0
Q
0
G
0
H
0
I
0
L
1
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 1 N: 0 D: 0 C: 1 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 1 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
5
C23H43N9O8S1
605.71
8.97
+1
3.41
-1.520
N-methyl-Glu
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor vessel, stroma of tumors
Homing
Prostrate cancer, Glioma, Lung cancer
Clotted-plasma proteins

Source & Reference

TumorHoPe2.0
TumorHoPe2
Weighing biointeractions between fibrin(ogen) and clot-binding peptides using microcantilever sensors
2017
Jou AP et al.J Pept Sci. 2017 Feb 23(2):162-171

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
Synthetic
Poly(3,4-ethylenedioxythiophene) (PEDOT)
Arginine at 2nd position with an N-methylation
Additional Detail Fields 1 fields
Poly(3,4-ethylenedioxythiophene) (PEDOT)